LIVE IN-PERSON EVENT

Marc van Pruijssen (general manager of Viroclinics Xellerate, a global logistics specialty services provider) will be co-presenting with Linda Xiang Wang (Clinical Studies Coordinator Medicago, a pioneer in plant-based therapeutics) at the Outsourcing in Clinical Trials East Coast. During this event, all innovations and expertise regarding clinical trials and global logistics will be discussed.

Meet us at booth #21 to learn more about:

– flexibility in scaling up and down
– solution-thinking
– ability to respond to fluctuations in needs and demands
… and More

Viroclinics Xellerate

Viroclinics Xellerate is a separate business unit within Viroclinics-DDL that helps biotech and pharmaceutical companies with global logistics and clinical trial services. With 38 partnering (processing) labs all over the world, Viroclinics Xellerate can guarantee 100% on time delivery and successful data management. For any kind of sampling, kits are custom-built, distributed, and retrieved with a track and trace code to be analyzed in our facilities. After a study, samples can be stored short-term or long-term in a bio bank. A 24/7 helpdesk ensures that all data is to be used successfully in analysis.

Our Speakers

Linda Xiang Wang

Clinical Studies Coordinator
Medicago 

Linda Xiang Wang is the Clinical Studies Coordinator at Medicago, a pioneer in plant-based therapeutics proudly rooted out of Quebec, Canada. Her current responsibilities include supporting CROs in the management of investigational product and clinical samples as well as the oversight of external vendors and third-party laboratories. Ms. Wang joined Medicago in 2019 as the Preclinical Studies Coordinator and helped to support the preclinical development of the SARS-CoV-2 program. Prior to her career at Medicago, Ms. Wang worked several years in the clinical trials and diagnostics industry. Additionally, she served as a Citizen advisor on the Clinical Excellence Committee on Health at INESSS in order to ensure both the scientific rigor and the professional and social acceptability of the work produced by the organization.
Academically, Ms. Wang was trained at Université Laval in psychology, neurosciences, and molecular medicine.

Marc van Pruijssen

General Manager
Viroclinics Xellerate

Marc van Pruijssen is General Manager Viroclinics Xellerate, a separate business unit within Viroclinics-DDL (a global virology & immunology CRO) that helps biotech and pharmaceutical companies with global logistics and clinical trial services. Marc van Pruijssen holds a Bsc. In international marketing, as well as management & organizational sciences. He performed an Msc, studying Transport & Logistics at TIAS-NIMBAS in Tilburg. Before joining Viroclinics-DDL in 2020, he has been responsible for a variety of developing supply chain functions and new business set up: supply chain planning, transport and distribution center operations, strategy development, program management and new product introductions. Next to that he is Board member and VP Marketing of the Council of Supply Chain Management Professionals (CSCMP) Benelux Round Table.

Subscribe to our newsletter to stay updated with the upcoming events:

About us

At Viroclinics – DDL, a Cerba Research Company, our purpose is to Improve Global Health – and to accelerate preventive and therapeutic solutions.  We do this by serving the biopharmaceutical industry with;

•  state of the art diagnostics
•  operational and logistical services
•  custom-made models in preclinical and clinical drug testing
•  expert advice on development of antivirals and vaccines

We offer a full range of virology services for new drug development programs and post-marketing surveillance of existing drugs and vaccines, ranging from traditional virology assays to the latest deep sequencing protocols for a very broad range of viruses. Our BSL2 and BSL3 labs enable us to perform analysis according to international accreditation.